SPECTRUM OF BENIGN BREAST DISORDERS IN A RURAL POPULACE: THE PERSPECTIVE OF A RURAL HOSPITAL

Full Article - PDF

Published: 2021-12-27

Page: 821-824


SARAVANAKUMARI VIJAYKUMAR

Department of Pathology, Sri Lakshminarayana Institute of Medical Sciences, Pondicherry-605502, India.

JAYALAKSHMI G *

Department of Pathology, Sri Lakshminarayana Institute of Medical Sciences, Pondicherry-605502, India.

*Author to whom correspondence should be addressed.


Abstract

Background: Benign breast diseases include infections, granulomatous inflammatory disorders, lipomas, fibrocystic disease, and fibroadenomas. Studies involving underserved populations living in rural areas reported from medical institutions situated in their localities are scarce.

Materials and Methods: We aimed to determine the proportion of benign breast diseases in a rural hospital during the COVID pandemic. A retrospective analysis of all breast disorders treated in the Department of Surgery between 01 April 2020 to 31 March 2021 was performed. Using biopsy and fine needle aspiration (FNA) registers and manually extracted case files, information such as demographic parameters, clinical history, physical examination, and investigations were obtained. The curated data was then analyzed using IBM SPSS for Windows version 22. 

Results: There were 36 patients in our study, with the majority (32; 88.9%) being women. The mean age and duration of symptoms of the study population were 39.19±13.90 (range, 15-74 years) and 4.6±4.8 months (range, two weeks to 24 months), respectively.

Conclusion: Even though the number of cases may be lower, the spectrum of benign breast diseases that included fibroadenoma, gynecomastia, fibrocystic disease, phyllodes, and granulomatous mastitis is similar to that of more extensive studies from other institutions. 

Keywords: Breast disorders, rural India, population, malignancy, gynecomastia


How to Cite

VIJAYKUMAR, S., & G, J. (2021). SPECTRUM OF BENIGN BREAST DISORDERS IN A RURAL POPULACE: THE PERSPECTIVE OF A RURAL HOSPITAL. UTTAR PRADESH JOURNAL OF ZOOLOGY, 42(24), 821–824. Retrieved from https://mbimph.com/index.php/UPJOZ/article/view/2792

Downloads

Download data is not yet available.

References

Chandan A, Ali I, Manerikar K, Singh G. A comparative study of surgical accesses to breast fibroadenoma. Int J Surg Orthop. 2017;3(4):162-168.

Ghahari S, Fallah R, Behnam L, Rad M, Farrokhi N, Ghayoomi R. Preoccupations and worries in women with breast cancer: A qualitative study. J Pharm Res Int. 2018;24(2):1-7.

Dnyaneshwar S J, Priyanka B K, Apoorv G, Arvind G V. A Histopathological study of neoplastic and non-neoplastic breast lesions at a rural tertiary care centre in India. Indian J Pathol Res Pract. 2017;6(2(Part-2)):387- 392.

Saadaat R, Abdul-Ghafar J, Haidary AM, Rahmani S, Atta N. Age distribution and types of breast lesions among Afghan women diagnosed by fine needle aspiration cytology (FNAC) at a tertiary care centre in Afghanistan: a descriptive cross-sectional study. BMJ Open. 2020;10(9):e037513.

Chinnaiah E, Nagireddy TV. A clinical study of benign breast diseases. Int J Surg Sci. 2020;4(1):287-290.

Dubey B, Meenai FJ. Spectrum of Benign Breast Lesions in Females of Age Group 11-60 Years - A Hospital Based Study. Saudi J Pathol Microbiol. 2019;04(11):861-867.

Kumar BS, Gole GN, Gole SG. A clinicopathological study of benign breast diseases: our experience at a rural medical college, Telangana. New Indian J Surg. 2018;9(2):204-209.

Kapoor B, Vaid P, Kapoor M, Kapoor BB, Kapoor S. Clinical and pathological correlation in benign breast diseases in women. Int J Reprod Contracept Obstet Gynecol. 2020;9(5):1825.

Ali EA, Talaat S. Ultrasound Lexicon in diagnosis and management of breast fibroadenoma: when to follow up and when to biopsy. Egypt J Radiol Nucl Med. 2020;51(1):17.

Ambika S, Manojkumar Y, Arunachalam S, Gowdhami B, Sundaram KK, Solomon RV, Venuvanalingam P, Akbarsha MA, Sundararaman M. Biomolecular interaction, anti-cancer and anti-angiogenic properties of cobalt (III) Schiff base complexes. Scientific Reports. 2019;9(1):1-4.

Le HT, Rimpilainen T, Mani SK, Murugesan A, Yli-Harja O, Candeias NR, Kandhavelu M. Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent. Scientific Reports. 2019;9(1):1- 1.

Bhettani MK, Rehman M, Altaf HN, et al. Correlation between body mass index and fibroadenoma. Cureus. Published online July 23, 2019.